{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:14:53Z","timestamp":1792656893919,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.joms.2005.07.010","type":"journal-article","created":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T07:20:54Z","timestamp":1130397654000},"page":"1567-1575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1255,"title":["Bisphosphonate-Induced Exposed Bone (Osteonecrosis\/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment"],"prefix":"10.1016","volume":"63","author":[{"given":"Robert E.","family":"Marx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Sawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishtasb","family":"Broumand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2005.07.010_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2005.07.010_bib2","first-page":"4253","volume":"21","author":"Migliorati","year":"2003","journal-title":"Bisphosphonates and oral cavity avascular bone necrosis"},{"key":"10.1016\/j.joms.2005.07.010_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates. A review of 63 cases","volume":"62","author":"Ruggerio","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2005.07.010_bib4","first-page":"268","article-title":"Bisphosphonates and avascular necrosis of the jaw","volume":"48","author":"Carter","year":"2003","journal-title":"Aust Dent J"},{"key":"10.1016\/j.joms.2005.07.010_bib5","first-page":"750","article-title":"Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates","volume":"22","author":"Estilo","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.joms.2005.07.010_bib6","first-page":"130","article-title":"Bisphosphonates\u2013Mechanism of action. Experimental and clinical pharmacology","volume":"23","author":"Martin","year":"2000","journal-title":"Auctr Preser"},{"key":"10.1016\/j.joms.2005.07.010_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0278-2391(83)80005-6","article-title":"Osteoradionecrosis\u2013A new concept of its pathophysiology","volume":"41","author":"Marx","year":"1983","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2005.07.010_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0030-4220(87)90136-8","article-title":"Studies in the radiobiology of osteoradionecrosis and their clinical significance","volume":"64","author":"Marx","year":"1987","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.joms.2005.07.010_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0002-9343(85)90057-9","article-title":"Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosis","volume":"79","author":"Zigic","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.joms.2005.07.010_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-137-1-200207020-00008","article-title":"High prevalence of osteonecrosis of the femoral head in HIV-infected adults","volume":"137","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joms.2005.07.010_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/CRIAI:25:1:13","article-title":"Osteonecrosis in patients with SLE","volume":"25","author":"Abu-Shakra","year":"2003","journal-title":"Clin Reo Allergy Immunol"},{"key":"10.1016\/j.joms.2005.07.010_bib12","series-title":"Reversible Pathogenetic Etiologies of Osteonecrosis in Osteonecrosis","first-page":"105","article-title":"Thrombophillis and hypofibrinolysis","author":"Ghreck","year":"2001"},{"key":"10.1016\/j.joms.2005.07.010_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S8756-3282(01)00655-X","article-title":"Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells","volume":"30","author":"Beek","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.joms.2005.07.010_bib14","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer Suppl"},{"key":"10.1016\/j.joms.2005.07.010_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2005.07.010_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199602223340802","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma","volume":"334","author":"Beresen","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2005.07.010_bib17","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.joms.2005.07.010_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharm Exp Thesopuctus"},{"key":"10.1016\/j.joms.2005.07.010_bib19","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Natl Acad Sci U S A"},{"key":"10.1016\/j.joms.2005.07.010_bib20","first-page":"1121","article-title":"Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnovers by penicillamine and the depletion of capper, an angiogenic cofactor","volume":"134","author":"Brem","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joms.2005.07.010_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1542\/peds.103.6.1145","article-title":"Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a","volume":"103","author":"Kaban","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.joms.2005.07.010_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin, an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O\u2019Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.joms.2005.07.010_bib23","first-page":"516a","article-title":"PS-341 (Bortazomib) is active in multiple myeloma. Preliminary report of a phase I trial of the proteasome inhibitor PS-341 in patients with hematologic malignancies","volume":"96","author":"Stinchcombe","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.joms.2005.07.010_bib24","first-page":"1329","article-title":"A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer","volume":"57","author":"Sim","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.joms.2005.07.010_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis","volume":"349","author":"Whyte","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2005.07.010_bib26","first-page":"91","article-title":"Osteonecrosis of the jaw associated with cancer chemotherapy","volume":"62","author":"Wang","year":"2004","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239105011870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239105011870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:16:42Z","timestamp":1759508202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239105011870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0278239105011870"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2005.07.010","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonate-Induced Exposed Bone (Osteonecrosis\/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2005.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}